Trials / Conditions / Retinopathy of Prematurity (ROP)

Retinopathy of Prematurity (ROP)

23 registered clinical trials studyying Retinopathy of Prematurity (ROP) — 11 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants NCT07502781	Hospital Clinic of Barcelona	N/A
Not Yet Recruiting	Retinopathy of Prematurity - Visual Function and Retinal Structure NCT07427719	Oslo University Hospital	—
Not Yet Recruiting	Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants NCT07112430	IWK Health Centre	Phase 1 / Phase 2
Not Yet Recruiting	Safety, PK and PD of FLQ-101 in Premature Neonates NCT07093255	FELIQS INC.	Phase 1
Not Yet Recruiting	The Correlation Between Red Cell Transfusion and Complications of Prematurity NCT07123948	Clinical Hospital Center Rijeka	—
Recruiting	Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity NCT06612541	Vanderbilt University Medical Center	—
Not Yet Recruiting	A Multicenter and Prospective Study of Screening Retinopathy of Prematurity in China NCT06729333	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	—
Recruiting	Efficacy and Safety of Low-dose Conbercept for Retinopathy of Prematurity Therapy NCT06717412	Wang Yusheng	N/A
Not Yet Recruiting	Long-term Ophthalmic Outcomes in Ex-premature Infants NCT06649513	Erasmus Medical Center	—
Recruiting	The Effect of Two Non-Pharmacological Methods on Pain During Retinopathy Examination NCT06694103	Sinem Basdemir	N/A
Completed	To Assess the Effect of Dexamethasone Eye Drops on the Retinopathy of Prematurity Outcome NCT06775353	Region Skane	—
Terminated	Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment With SHP607 in Extremely P NCT04506619	Oak Hill Bio Ltd	—
Completed	Extension Study to Evaluate the Long-term Outcomes of Subjects in Study 20090 NCT04015180	Bayer	Phase 3
Completed	Aflibercept for Retinopathy of Prematurity - Intravitreal Injection Versus Laser Therapy NCT04004208	Bayer	Phase 3
Recruiting	A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Prematur NCT03253263	OHB Neonatology Ltd.	Phase 2
Completed	Rainbow Extension Study NCT02640664	Novartis Pharmaceuticals	Phase 3
Completed	Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for t NCT02386839	Shire	Phase 2
Completed	Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity NCT02134457	University Hospital Freiburg	Phase 2
Terminated	Inositol to Reduce Retinopathy of Prematurity NCT01954082	NICHD Neonatal Research Network	Phase 3
Withdrawn	VEGF In Systemic Circulation Of ROP-infants NCT01470430	University Hospital Freiburg	—
Completed	IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity NCT01096784	Shire	Phase 2
Completed	ROP Check Database Premature Infant Outcomes NCT07312669	Alaska Blind Child Discovery	—
Completed	Study on Effective Mydriasis in Premature Infants NCT01054027	Georgetown University	N/A